| 000 | 01859 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517144333.0 | ||
| 264 | 0 | _c20170803 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jix113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Sulggi | |
| 245 | 0 | 0 |
_aImmunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _c04 2017 |
||
| 300 |
_a1270-1274 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aKynurenine _xblood |
| 650 | 0 | 4 |
_aLipopolysaccharide Receptors _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTryptophan _xblood |
| 650 | 0 | 4 |
_aUganda _xepidemiology |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aByakwaga, Helen | |
| 700 | 1 | _aBoum, Yap | |
| 700 | 1 | _aBurdo, Tricia H | |
| 700 | 1 | _aWilliams, Kenneth C | |
| 700 | 1 | _aLederman, Michael M | |
| 700 | 1 | _aHuang, Yong | |
| 700 | 1 | _aTracy, Russell P | |
| 700 | 1 | _aCao, Huyen | |
| 700 | 1 | _aHaberer, Jessica E | |
| 700 | 1 | _aKembabazi, Annet | |
| 700 | 1 | _aBangsberg, David R | |
| 700 | 1 | _aMartin, Jeffrey N | |
| 700 | 1 | _aHunt, Peter W | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 215 _gno. 8 _gp. 1270-1274 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jix113 _zAvailable from publisher's website |
| 999 |
_c27002983 _d27002983 |
||